ArticleIndian journal of endocrinology and metabolism
Ensuring Continuity of Gender-Affirming Care in India: Clinical and Medico-Legal Guidance in the Current Regulatory Framework: Endocrine Society of India Position Statement.
Article in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent amendments to the Transgender Persons (Protection of Rights) Act, 2026 have introduced changes in the legal definition, certification processes, and regulatory oversight of transgender identity in India, needing clarity on medical management of gender incongruent individuals. This position statement provides practical, evidence-based, and medico-legally sound guidance for endocrinologists to ensure continuity of care for individuals with gender incongruence within the evolving legal framework. The document emphasises the distinction between clinical care and legal certification and advocates adherence to internationally and nationally accepted standards, including World Professional Association for Transgender Health Standards of Care Version 8 and Endocrine Society guidelines, keeping in mind that the law does not forbid, prevent, or regulate through this act, as amended, the interventions by endocrinologists. It highlights strengthened penal provisions addressing coercion, inducement, and non-consensual interventions, underscoring the need for robust safeguards in clinical decision-making. Key recommendations include comprehensive clinical assessment, individualised risk-benefit evaluation, and meticulous documentation, particularly regarding informed consent, decisional capacity, voluntariness, and absence of coercion. The importance of confidentiality, alongside compliance with statutory reporting requirements, is also addressed. A practical distinction is made between continuation of established care and initiation of new interventions, with the latter requiring enhanced procedural diligence. The continuity of care in previously treated subjects is also emphasised. This guidance supports clinicians in delivering uninterrupted, ethical, and legally compliant gender-affirming care, reinforcing that patient-centred, evidence-based practice remains paramount, irrespective of legal definition concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.